Return-Path: <jirlplnle@dhce.com>
Delivered-To: em-ca-bait-baseline@em.ca
Received: (qmail 22782 invoked by uid 115); 21 Apr 2005 07:34:16 -0000
Received: from jirlplnle@dhce.com by churchill by uid 64011 with qmail-scanner-1.22 
 (clamdscan: 0.75-1. spamassassin: 2.63.  Clear:RC:0(220.104.114.92):. 
 Processed in 0.118765 secs); 21 Apr 2005 07:34:16 -0000
Received: from p4092-ipbf33marunouchi.tokyo.ocn.ne.jp (220.104.114.92)
  by churchill.factcomp.com with SMTP; 21 Apr 2005 07:34:15 -0000
Received: from anabaptist.cdsinc.net ([64.118.96.196])
 by doctorate.ekblad.com
 (Sun Java System Messaging Server 6.1 HotFix 0.01 (built Aug 21 2004))
 with SMTP id <0ICD00HGMY1D01Q0@doctorate.ekblad.com> for tomg@em.ca
 (ORCPT tomg@em.ca); Thu, 21 Apr 2005 12:37:19 +0400 (IST)
Received: (qmail 71873 invoked from network); Thu, 21 Apr 2005 01:43:19 -0700
Received: from unknown (HELO cooperate.coates.net) (66.241.220.27)
 by server-0.particle-34.cdsinc.net with SMTP; Thu, 21 Apr 2005 12:43:19 +0400
Received: by cooperate with Internet Mail Service (5.5.2714.93)
	id <HIV67BPY>; Thu, 21 Apr 2005 11:38:19 +0300
Date: Thu, 21 Apr 2005 06:42:19 -0200
From: "Ron Ortiz" <jirlplnle@dhce.com>
Subject: Experts are jumping all 0ver this st0ck
To: <tomg@em.ca>
References: <%RND_ALFABET@cdsinc.net>
In-Reply-To: <%RND_ALFABET@cdsinc.net>
Message-ID: <495620440259.MPC09332@cooperate.ekblad.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,0OO,OO0 EST
Current Price: 0.O6
2OO4 Success lead into an exciting 20O5.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutica| products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stab|e of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydroch|orrde, 10-Deacetyl Baccatin, Paclitaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 20OO with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Neutraceutical products wor|dwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge grOup of pheno|ic secondary 
metabo|ites of plants that inc|ude more than 2,O00 different known 
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wa||s of the blood vesse|s inc|uding capi|laries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 2OO4-20O5 are more then  $1OO mi|li0n USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Thursday! Go SCRE.

Penny stOcks are considered high|y specu|ative and may be unsuitab|e 
for all but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3000 dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.

If you wish to stop future mai|ings, or if you fee| you have been
wrongful|y placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to   st0ck1005 @yahoo.com      

